Smallpox and Mpox Vaccine

Drug identity checked against registry records

Also recorded as JYNNEOS

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOSNCT04957485SIGA TechnologiesPhase 2Active not recruiting2027-01-01Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.